Utah Retirement Systems Bristol Myers Squibb CO Transaction History

Utah Retirement Systems

  • $8.7 Billion
  • Q3 2024

A detailed history of Utah Retirement Systems transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Utah Retirement Systems holds 335,530 shares of BMY stock, worth $19.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
335,530
Previous 334,230 0.39%
Holding current value
$19.5 Million
Previous $13.9 Million 25.09%
% of portfolio
0.2%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $51,557 - $67,275
1,300 Added 0.39%
335,530 $17.4 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $756,700 - $996,212
-18,800 Reduced 5.33%
334,230 $13.9 Million
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $9,596 - $10,880
-200 Reduced 0.06%
353,030 $19.1 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $446,016 - $532,220
-9,200 Reduced 2.54%
353,230 $18.1 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $86,835 - $97,095
1,500 Added 0.42%
362,430 $21 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $1.18 Million - $1.31 Million
-18,500 Reduced 4.88%
360,930 $23.1 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $78,851 - $89,436
1,200 Added 0.32%
379,430 $26.3 Million
Q4 2022

Feb 15, 2023
SELL
$68.48 - $81.09 $246,528 - $291,924
-3,600 Reduced 0.94%
378,230 $27.2 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $234 - $138,312
1,800 Added 0.47%
381,830 $27.1 Million
Q2 2022

Aug 16, 2022
SELL
$72.62 - $79.98 $668,104 - $735,816
-9,200 Reduced 2.36%
380,030 $29.3 Million
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $989,828 - $1.19 Million
-16,100 Reduced 3.97%
389,230 $28.4 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $48,267 - $56,268
900 Added 0.22%
405,330 $25.3 Million
Q3 2021

Nov 16, 2021
SELL
$59.17 - $69.31 $1.27 Million - $1.49 Million
-21,500 Reduced 5.05%
404,430 $23.9 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $563,381 - $613,522
-9,100 Reduced 2.09%
425,930 $28.5 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $1.13 Million - $1.27 Million
-19,100 Reduced 4.21%
435,030 $27.5 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $1.13 Million - $1.28 Million
19,500 Added 4.49%
454,130 $28.2 Million
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $166,547 - $184,556
2,900 Added 0.67%
434,630 $26.2 Million
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $794,890 - $929,305
-14,500 Reduced 3.25%
431,730 $25.4 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $4,640 - $6,743
-100 Reduced 0.02%
446,230 $24.9 Million
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $6.66 Million - $8.68 Million
135,273 Added 43.49%
446,330 $28.7 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $55,601 - $65,923
1,300 Added 0.42%
311,057 $15.8 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $34,714 - $38,386
778 Added 0.25%
309,757 $14 Million
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $176,735 - $210,734
3,917 Added 1.28%
308,979 $14.7 Million
Q4 2018

Feb 08, 2019
BUY
$48.76 - $63.23 $34,132 - $44,261
700 Added 0.23%
305,062 $15.9 Million
Q3 2018

Nov 13, 2018
BUY
$55.19 - $62.25 $77,266 - $87,150
1,400 Added 0.46%
304,362 $18.9 Million
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $207,173 - $258,218
-4,100 Reduced 1.34%
302,962 $16.8 Million
Q1 2018

May 15, 2018
BUY
$59.92 - $68.98 $29,960 - $34,490
500 Added 0.16%
307,062 $19.4 Million
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $251,748 - $274,470
4,200 Added 1.39%
306,562 $18.8 Million
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $16.7 Million - $19.3 Million
302,362
302,362 $19.3 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email